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Background-—The role of arterial load in severe aortic stenosis is increasingly recognized. However, patterns of pulsatile load and
their implications in this population are unknown. We aimed to assess the relationship between the arterial properties and both
(1) left ventricular remodeling and ﬁbrosis and (2) the clinical course of patients with severe aortic stenosis undergoing aortic valve
replacement (AVR).
Methods and Results-—We enrolled 38 participants with symptomatic severe aortic stenosis scheduled to undergo surgical AVR.
Aortic root characteristic impedance, wave reﬂections parameters (reﬂection magnitude, reﬂected wave transit time), and
myocardial extracellular mass were measured with cardiac magnetic resonance imaging and arterial tonometry Cardiac magnetic
resonance imaging was repeated at 6 months in 30 participants. A reduction in cellular mass (133.6 versus 113.9 g; P=0.002) but
not extracellular mass (42.3 versus 40.6 g; P=0.67) was seen after AVR. Participants with higher extracellular mass exhibited
greater reﬂection magnitude (0.68 versus 0.54; P=0.006) and lower aortic root characteristic impedance (56.3 versus 96.9 dynes/
s per cm5; P=0.006). Reﬂection magnitude was a signiﬁcant predictor of smaller improvement in the quality of life (Kansas City
Cardiomyopathy Questionnaire score) after AVR (R=0.51; P=0.0026). The 6-minute walk distance at 6 months after AVR was
positively correlated with the reﬂected wave transit time (R=0.52; P=0.01).
Conclusions-—Consistent with animal studies, arterial wave reﬂections are associated with interstitial volume expansion in severe
aortic stenosis and predict a smaller improvement in quality of life following AVR. Future trials should assess whether wave
reﬂections represent a potential therapeutic target to mitigate myocardial interstitial remodeling and to improve the clinical status
of this patient population. ( J Am Heart Assoc. 2019;8:e010271. DOI: 10.1161/JAHA.118.010271.)
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S evere aortic stenosis (AS) is associated with left ventric-ular (LV) hypertrophy and ﬁbrosis because of its effect of
left ventricular (LV) pressure overload. The extent of LV
myocardial ﬁbrosis is an independent predictor of intermedi-
ate- and long-term mortality among patients undergoing aortic
valve replacement (AVR) for severe AS.1 Despite the clinical
relevance of myocardial ﬁbrosis in AS, its underlying deter-
minants before and after AVR are poorly understood. It was
recently shown that, on average, extracellular volume fraction
(ECVF) and extracellular mass do not regress after aortic valve
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replacement,2,3 suggesting that additional factors inﬂuence
the degree of ﬁbrosis in severe AS.
In addition to the properties of the aortic valve, LV
afterload is determined by the properties of the systemic
arterial tree (ie, arterial load).4,5 The importance of pulsatile
arterial load in AS has been increasingly recognized.6
Arterial load is best characterized by analyses of aortic
pressure–ﬂow relations, which allow for quantiﬁcation of
resistive load and various components of pulsatile load.4,5
Arterial load adds to valvular load in patients with severe
AS7 and becomes the main determinant of the LV loading
pattern after successful correction of valvular stenosis. The
magnitude and timing of wave reﬂections in the arterial tree
constitute important components of pulsatile load.4,5 In
every cardiac cycle, the pulse wave generated by the left
ventricle travels forward in arteries and is partially reﬂected
at sites of impedance mismatch, such as points of
branching or change in wall diameter or material properties
along the arterial tree. Wave reﬂections are conducted back
to the heart, merging into a discrete reﬂected (backward)
wave that increases the mid- to late systolic LV load in
older adults.5,8 Mid- to late systolic load from wave
reﬂections has been shown to cause hypertrophy and
ﬁbrosis in animal models of pressure overload and has
been associated with LV hypertrophy, diastolic dysfunction,
atrial dysfunction, and an increased risk of heart failure in
various human studies,4,8–14 independent of the peak
arterial pressure. To the degree that wave reﬂections
contribute to pulsatile arterial load in AS, they may also
determine maladaptive remodeling in this patient population
and the clinical course after correction of aortic valvular
stenosis.
This study was designed to test the hypothesis that arterial
wave reﬂections and large-artery stiffness are associated with
LV remodeling and ﬁbrosis in patients with severe AS and with
the clinical course of these patients after surgical AVR.
Methods
ACRIN PA 4008 was conducted by the American College of
Radiology Imaging Network (ACRIN) across 5 institutions in
Pennsylvania (University of Pittsburg Medical Center, Hospital
of the University of Pennsylvania, Corporal Michael J.
Crescenz VA Medical Center, Penn State Milton S. Hershey
Medical Center, and Lancaster General Health). The study was
approved by the institutional review boards of ACRIN and
each enrolling center. All participants provided written
informed consent.
The data, analytic methods, and study materials are not
publicly available for purposes of reproducing the results or
replicating the procedures. Such data may be made available
to other researchers for collaborative research through the
establishment of appropriate data-sharing agreements.
Study Population
We prospectively enrolled participants aged ≥18 years who
had severe symptomatic AS (estimated aortic valve area
<1 cm2 on a transthoracic echocardiogram or cardiac
catheterization performed within 4 months before enroll-
ment), surgical AVR planned within 4 weeks after enrollment,
and no contraindications to undergo gadolinium contrast-
enhanced cardiac magnetic resonance imaging (CMR) before
AVR.
Key exclusion criteria were as follows: (1) LV ejection
fraction <50% before enrollment, (2) previous aortic valve
surgery, (3) infective endocarditis, (4) moderate or severe
aortic regurgitation, (5) history of myocardial infarction or
segmental wall motion abnormalities, (6) known hemodynam-
ically signiﬁcant coronary artery disease, (7) unstable angina
in the previous month, (8) glomerular ﬁltration rate <45 mL/
min per 1.73 m2, (9) bicuspid aortic valve, (10) resting heart
rate >120 beats/min or blood pressure >180/100 mm Hg,
(11) pregnancy, (12) inability to undergo CMR or conditions
that would make study measurements less accurate or
unreliable (ie, atrial ﬁbrillation, anatomic neck characteristics
Clinical Perspective
What Is New?
• Arterial wave reﬂections are key correlates of left ventricular
interstitial expansion in patients with severe aortic stenosis.
• The magnitude of arterial wave reﬂections predicts the
clinical course (change in symptoms and quality of life
measures) after aortic valve replacement, with a smaller
improvement among patients with high reﬂection
magnitude.
• The timing of wave reﬂections correlates with submaximal
exercise capacity at 6 months after aortic valve
replacement.
What Are the Clinical Implications?
• Arterial load, in particular mid to late systolic load from
wave reﬂections, appears to be an important contributor to
left ventricular maladaptive remodeling and a poor clinical
course in aortic stenosis patients undergoing aortic valve
replacement.
• Future studies should aim to assess whether reducing wave
reﬂections with therapeutic interventions can improve
quality of life and/or the regression of left ventricular
ﬁbrosis in patients with severe aortic stenosis undergoing
aortic valve replacement.
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impeding arterial tonometry, inability to perform an adequate
breath hold for CMR acquisitions) or reliable postoperative
follow-up unlikely, (13) peripheral vascular disease, (14) life
expectancy <1 year.
Study Procedures
CMR scans, arterial tonometry recordings, and quality-of-life
assessments were performed before AVR and repeated
6 months 2 weeks after AVR. A more detailed description
of the study procedures is presented in Data S1. Figure S1
shows the study participant ﬂow and procedures.
Arterial Tonometry
Arterial tonometry (Figure 1) was performed immediately
before or after CMR using a SphygmoCor Px device (AtCor
Medical), equipped with a high-ﬁdelity applanation tonometer.
An aortic pressure waveform was obtained via the generalized
transfer function of the Sphygmocor device. Carotid–femoral
pulse wave velocity (PWV) was obtained via sequential carotid
and femoral tonometry. For sensitivity analyses, we performed
an additional measurement of aortic PWV using phase-contrast
magnetic resonance imaging (MRI) with in-plane velocity
encoding from head to foot in the aortic “candy cane” view.
Measurements of LV Mass and Flow
CMR scans were performed using a 1.5-T whole-body MRI
scanner (Avanto or Espree; Siemens) equipped with a phase-
array cardiac coil. LV volumes and ejection fraction were
determined using balanced steady-state free-precession cine
imaging. LV volumes and mass were measured from manually
traced short-axis stack cine images using CMR42 software
(Circle CVI).
To compute the impedance of the systemic arterial tree
(aortic input impedance) and assess wave reﬂections, knowl-
edge of the time-resolved proximal aortic inﬂow (which equals
LV outﬂow) is required. Proximal aortic ﬂow was measured
using through plane velocity-encoded phase-contrast imaging
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Figure 1. Assessment of pressure-ﬂow relations and wave reﬂections. A, The central pressure waveform obtained via arterial tonometry and
the ﬂow waveform obtained via through-plane phase-contrast magnetic resonance imaging of the ascending aorta. B and C, The modulus (B) and
phase (C) of the aortic input impedance spectrum (Zin). The dashed line in panel B represents the proximal aortic Zc. D, Results of wave
separation analysis in which the pressure wave has been separated into forward (Pf) and backward (Pb) waves. The double-headed arrow
represents the apparent reﬂected wave transit time (time lag between the forward and the backward waves). ZC indicates characteristic
impedance; Zin, input impedance.
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with a plane prescribed perpendicular to the long axis of the
aorta at the level of the right pulmonary artery (Figure 1).
When signiﬁcant aliasing impeded a reliable assessment of
the proximal aortic systolic ﬂow proﬁle, we used the systolic
LV outﬂow proﬁle obtained from a 2-dimensional, encoded, in-
plane, phase-contrast acquisition in the 3-chamber LV long-
axis plane. In all cases, diastolic outﬂow was set to 0 and the
time-integral of the systolic ﬂow curve was calibrated to the
stroke volume measured by LV cine imaging.
Arterial Load
Arterial load was quantiﬁed using custom-designed software
programmed in Matlab (MathWorks), as described previously
(Figure 1).15 After alignment of the pressure–ﬂow pair (Fig-
ure 1A), pressure–ﬂow analyses were performed to obtain
aortic input impedance modulus (Figure 1B) and phase
(Figure 1C). Proximal aortic characteristic impedance (ZC),
which describes the relationship between pulsatile pressure
and ﬂow in the absence of wave reﬂections, was computed as
the mean value of input impedance moduli at higher harmonics
(dashed horizontal line in Figure 1B). This was followed by
wave separation (Figure 1D) into forward and reﬂected
waves.5,15 Reﬂection magnitude was calculated as backward
wave amplitude divided by forward wave amplitude. Wave
separation is based purely on the pulsatile components of
pressure and ﬂow and thus does not incorporate mean load
(total peripheral resistance). Forward and reﬂected waves thus
ﬂuctuate around 0 (Figure 1D). Reﬂected wave transit time
(double-headed arrow in Figure 1D) represents the difference
in the time at which forward and backward waves start adding
to pressure. A short reﬂected wave transit time favors greater
overlap between ventricular ejection and systolic load imposed
by wave reﬂections. Valvuloarterial impedance was computed
as follows: (mean transvalvular gradient + systolic blood
pressure)/stroke volume index. Table S1 provides a glossary
of the main indexes of arterial load and ventricular–arterial
interactions presented in this article.
Extracellular Volume Measurements
We used a modiﬁed Look-Locker inversion recovery, or
MOLLI,12 sequence to assess T1 times before and after the
intravenous administration of gadolinium contrast (Multi-
Hance; 0.15 mmol/kg of body weight or equivalent) in a
midventricular short-axis slice. MOLLI sequences were not
available at one of the recruiting centers but were performed
in 31 participants enrolled across the other sites. Myocardial
T1 measurements were performed before and at several time
points at least 10 minutes after gadolinium administration.
Gadolinium administration increases T1 relaxivity (expressed
as 1/T1) of blood and myocardium. Blood and myocardial T1
measurements were used to compute the myocardium–blood
partition coefﬁcient (k)1).5,14,18 as the slope of the blood 1/
T1 over the myocardial 1/T1 change, via linear regression.
The LV ECVF was computed as k9(1hematocrit). LV
extracellular mass was computed as LV mass multiplied by
ECVF. LV cellular mass was computed as LV mass multiplied
by (1ECVF).
Quality of Life and Functional Assessments
We measured quality of life using the Kansas City Cardiomy-
opathy Questionnaire (KCCQ). A 6-minute walk distance
(6MWD) test was performed during the post-AVR visit
(6 months after AVR).
Statistical Analysis
Our primary analyses tested the hypothesis that prevalent
arterial properties are associated with LV remodeling and the
clinical course after AVR. We assessed (1) the relationship
between arterial properties and parameters at baseline (before
AVR) and (2) the relationship between arterial properties and
the change in key parameters after AVR. For analyses related
to the 6MWD (which was only performed after AVR), the
relationship with arterial load parameters measured after AVR
was assessed. For intuitive assessments, we compared
parameters of interest using unpaired t tests among patients
above or below the median value of key arterial or LV
variables. Correlation coefﬁcients and 95% CIs were also
computed. Box-Cox transformations were applied as appro-
priate to normalize the distribution of parameters and/or to
model residuals during analyses. Comparisons between pre-
and post-AVR values of key physiologic parameters were
performed using paired t tests. If appropriate, we also
performed analyses adjusted for brachial blood pressure
measurements using ANCOVA or multivariable linear regres-
sion. All statistical tests were 2-sided. A P value threshold of
0.05 was used to deﬁne statistical signiﬁcance. Analyses were
performed using the Matlab statistics and machine learning
toolbox (Mathworks) and SPSS for Windows v22 (IBM Corp).
Results
General characteristics of the study population are shown in
Table 1. In general, the population was composed of elderly
(mean age: 72 years), predominantly male (68.4%), predom-
inantly white (94.7%) participants.
Among 38 participants who underwent baseline study
procedures, there were 4 discontinuations before the post-
AVR assessment due to the participants’ wish to withdraw
from the study (n=2) or decision to not pursue AVR (n=2). In 4
cases, the 6-month CMR could not be completed because of
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the postoperative implantation of a pacemaker or implantable
cardioverter-debrillator (n=4).
In another case, renal dysfunction ensued postoperatively,
precluding ECVF measurements but not other MRI
measurements and arterial measurements. Table S2 com-
pares participants who underwent a follow-up CMR (n=30)
versus those who did not (n=8). Participants who could not
undergo a follow-up CMR tended to be older and demon-
strated a lower prevalence of thiazide use at baseline.
LV Mass, Geometry, and Myocardial Fibrosis
Before and After AVR
Table 2 presents a comparison of key arterial parameters
before and after AVR. Figure 2 demonstrates changes in key LV
parameters. LV end-diastolic volume was reduced from 157.1
to 144.8 mL (P=0.018), whereas LV mass decreased from
166.1 to 147.8 g (P<0.0001). Cellular mass decreased from
133.6 to 113.9 g (P=0.002), whereas extracellular mass was
unchanged (42.3 versus 40.6 g; P=0.67). There were no
signiﬁcant changes in myocardial ECVF (24.0 to 26.9%;
P=0.20) or the gadolinium partition coefﬁcient (0.40 versus
0.45; P=0.18).
Relationship Between Arterial Properties and
Interstitial Expansion at Baseline (Before AVR)
Participants with extracellular mass above the median value
(35.6 g) demonstrated greater reﬂection magnitude (0.68
Table 1. Baseline Characteristics of Study Population (n=38)
Characteristic MeanSD or n (%)
Age, y 729.3
Male sex 26 (68.4)
Ethnicity
White 36 (94.7)
Black 2 (5.3)
BMI, kg/m2 30.76.38
Serum creatinine 0.900.2
Aortic valve area, cm2 0.750.14
Aortic valve area index, cm2/m2 0.370.08
Mean transvalvular gradient, mm Hg 48.414.4
Peak transvalvular gradient, mm Hg 77.224.4
Valvuloarterial impedance, mm Hg/mL per m2 4.241.08
Systolic blood pressure, mm Hg 135.220.4
Diastolic blood pressure, mm Hg 72.911.1
Mean arterial pressure, mm Hg 98.713.2
Pulse pressure, mm Hg 6923.8
Heart rate, beats/min 63.513.3
Syncope 3 (7.69)
Dyspnea 26 (68.4)
Angina 1 (2.6)
Diabetes mellitus 12 (31.6)
Hypertension 33 (86.8)
NYHA class
I 10 (26.3)
II 19 (50)
III/IV 9 (23.7)
Medication use
Aspirin 31 (81.6)
ACEIs or ARBs 24 (63.2)
b-Blockers 22 (57.9)
Calcium channel blockers 8 (21.1)
Thiazide diuretics 12 (31.6)
Loop diuretics 6 (15.8)
Hydralazine use 1 (2.6)
Long-acting nitrate 1 (2.6)
Aldosterone antagonist 0 (0)
ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor
blocker; BMI, body mass index; NYHA, New York Heart Association.
Figure 2. Left ventricular (LV) mass, extracellular volume fraction
(ECVF), and cellular and extracellular mass before and after aortic
valve replacement (AVR). P values were obtained with the paired
t test.
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versus 0.54; P=0.006) and lower ascending aortic Zc (56.3
versus 96.9 dynes/s per cm5; P=0.0225; Figure 3). Extracel-
lular mass did not demonstrate signiﬁcant relationships with
standard blood pressure measurements, reﬂected wave-
transit time, valvuloarterial impedance, or carotid-femoral
PWV (Table S3).
In contrast to extracellular mass, there were no relationships
between cellular mass and arterial properties. When partici-
pants were stratiﬁed by the median value of cellular mass, LV
mass, or ECVF, no signiﬁcant differences in reﬂection magni-
tude or timing (reﬂected wave transit time) were found.
Relationships Between Arterial Properties at
Baseline and Improvements in Quality of Life
In the overall population, there was a signiﬁcant improvement
in quality of life. The overall summary KCCQ score improved
from 69.4 to 88.4, a 19-point increase (P<0.0001). There
were signiﬁcant average improvements in all domains of the
KCCQ (Figure S2).
Reﬂection magnitude at baseline was a signiﬁcant predic-
tor of the change in KCCQ scores after AVR (Figure 4, left
panel), with signiﬁcantly lower improvement among partici-
pants with higher reﬂection magnitude (R=0.51; P=0.0026).
Participants who exhibited reﬂection magnitude values above
the median value (0.65) experienced much less improvement
in quality of life with AVR (change in KCCQ: 9.37 points; 95%
CI, 0.3 to 19.0), compared with those who exhibited
reﬂection magnitudes below the median value (29 points; 95%
CI, 19.7 to 39; P=0.007; Figure 4, middle panel). Reﬂection
magnitude predicted the change in multiple domains of the
KCCQ, including the clinical summary score, social limitation
score, quality of life score, overall symptom and symptom
burden scores, and physical limitation score (Figure 4, right
panel; Table S4).
Standard blood pressure values did not predict the change in
KCCQ (systolic blood pressure: R=0.16, P=0.38; diastolic blood
pressure: R=0.11; P=0.53; pulse pressure: R=0.21; P=0.23).
Change in Arterial Parameters After AVR
Table 2 and Figure 5 show paired comparisons of arterial
parameters before versus after AVR. There were no signiﬁcant
changes in reﬂection magnitude (0.62% versus 0.63%;
P=0.810) or proximal aortic root Zc (86.6 versus 85.5
dynes/s per cm5; P=0.900). However, there was a signiﬁcant
reduction in total arterial compliance (1.27 versus 1.08 mL/
mm Hg; P=0.008) and a pronounced increase in carotid-
femoral PWV (8.78 versus 11.2 m/s; P=0.015), as measured
with arterial tonometry, and in thoracic aortic PWV (5.54
Table 2. Paired Changes in Key LV and Arterial Parameters Between the Pre- and Post-AVR Assessments
Parameter Pre-AVR, mean (95% CI) 6-mo Post-AVR, mean (95% CI) Change, mean (95% CI) P Value
LV EDV, mL 157.1 (138.6–175.7) 144.8 (127.3–162.3) 12.3 (22.5 to 2.2) 0.018
LV ESV, mL 58.3 (48.2–68.4) 51.7 (43.6–59.8) 6.6 (13.3 to 0.1) 0.055
LV mass, g 166.1 (147.3–184.8) 147.8 (131.8–163.8) 18.2 (25.5 to 11) <0.0001
LV ejection fraction, % 63.8 (60.5–67.1) 65.1 (62.5–67.6) 1.3 (1.4 to 3.9) 0.20
ECVF, % 24.01 (20.95–27.07) 26.91 (22.73–31.1) 2.91 (1.65 to 7.46) 0.20
Gadolinium partition coefficient 0.4 (0.35–0.45) 0.45 (0.38–0.51) 0.05 (0.02 to 0.12) 0.18
Cellular mass, g 133.6 (115.4–151.8) 113.9 (95.8–132.1) 19.6 (31.2 to 8.1) 0.002
Extracellular mass, g 42.26 (33.97–50.54) 40.56 (32.89–48.24) 1.69 (9.87 to 6.48) 0.67
Reflection magnitude 0.62 (0.56–0.67) 0.63 (0.58–0.67) 0.01 (0.06 to 0.07) 0.81
Aortic Zc, dynes/s/cm5 86.6 (63–110.2) 85.5 (67.4–103.5) 1.1 (18.4 to 16.2) 0.90
Total arterial compliance, mL/mm Hg 1.27 (0.99–1.55) 1.08 (0.84–1.32) 0.19 (0.32 to 0.05) 0.008
CF PWV (tonometry) 8.78 (7.44–10.12) 11.2 (9.7–12.69) 2.41 (0.53–4.3) 0.015
Aortic PWV (phase-contrast MRI) 5.54 (4.46–6.62) 6.80 (5.54–8.06) 1.26 (0.17–2.35) 0.026
Total peripheral resistance, dynes/s/cm5 1337 (1194–1481) 1488 (1320–1657) 151 (42–260) 0.008
Central SBP, mm Hg 134.2 (122.4–146) 139.1 (128.2–150) 4.8 (5.3 to 14.8) 0.34
Brachial SBP, mm Hg 142.5 (132.1–152.8) 150.3 (138.8–161.8) 7.8 (3.6 to 19.3) 0.17
DBP, mm Hg 73.1 (69.6–76.6) 71.9 (67.1–76.8) 1.2 (6.6 to 4.2) 0.66
Mean arterial pressure, mm Hg 99.2 (94.2–104.2) 98.8 (92.7–104.9) 0.4 (6.1 to 5.2) 0.88
Values were compared using paired t tests. AVR indicates aortic valve replacement; CF, carotid-femoral; DBP, diastolic blood pressure; ECVF, extracellular volume fraction; EDV, end-
diastolic volume; ESV, end-systolic volume; LV, left ventricular; MRI, magnetic resonance imaging; PWV, pulse wave velocity; SBP, systolic blood pressure; Zc, characteristic impedance.
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versus 6.80 m/s; P=0.026), as measured with phase-contrast
MRI. There was also an increase in total peripheral resistance
(1337 versus 1488 dynes/s per cm5; P=0.008).
There was no relationship between the change in carotid-
femoral PWV and the change in brachial systolic blood
pressure (R=0.10; P=0.683) or diastolic blood pressure
(R=0.35; P=0.125). Similarly, there was no relationship
between the change in thoracic aortic PWV and the change
in brachial systolic blood pressure (R=0.04; P=0.870) or
diastolic blood pressure (R=0.277; P=0.251).
Predictors of the 6MWD at 6 Months After AVR
The mean 6MWD was 339 m (95% CI=291–386 m). The
6MWD was positively associated with the reﬂected wave
transit time (R=0.52; P=0.010; Figure 6). Participants with
reﬂected wave transit time below the median value (<40 ms)
walked shorter distances (285 m; 95% CI, 216.9353) than
those with longer reﬂected wave transit time (418 m; 95% CI,
353.2483.6; P=0.011). There was no relationship between
the 6MWD and reﬂection magnitude (R=0.11; P=0.590).
There was a signiﬁcant relationship between 6MWD and
systolic blood pressure (R=0.48; P=0.011), as well as
between 6MWD and diastolic blood pressure (R=0.51;
P=0.007). After adjustment for systolic blood pressure, the
difference in 6MWD persisted between participants with a
reﬂected wave transit time <40 ms (296 m; 95% CI, 226–
365) and ≥40 ms (409 m; 95% CI, 342475; P=0.037).
However, after adjustment for diastolic blood pressure,
6MWD was not signiﬁcantly different between participants
with reﬂected wave transit time <40 versus ≥40 ms
(P=0.100). In a linear regression model in which both
reﬂected wave transit time and diastolic blood pressure were
included as independent (explanatory) variables and reﬂected
wave transit time was the independent (response) variable,
diastolic blood pressure (standardized b=0.53; P=0.016), but
not reﬂected wave transit time (standardized b=0.05;
P=0.810), was independently associated with 6MWD.
Discussion
Our study provides several novel ﬁndings. First, we demon-
strated, for the ﬁrst time, that systolic load from arterial wave
reﬂections is associated with greater extracellular mass in
patients with severe AS, whereas aortic root Zc (which
governs arterial load in the absence of wave reﬂection) was
not. Second, we demonstrated that wave reﬂection
Figure 3. Reﬂectionmagnitude and aortic root Zc in patients with
extracellular mass above vs below the median value at baseline
(pre-AVR). P values were obtained with the unpaired t test. AVR
indicates aortic valve replacement; Zc, characteristic impedance.
Figure 4. A, Relationship between wave reﬂection magnitude measured at baseline and the improvement in the KCCQ summary. B, Mean
changes in the KCCQ summary score among patients with reﬂection magnitude above vs below the median value (65%). The P value was
obtained with the unpaired t test. C, The correlation coefﬁcients (and 95% CIs) between pre-AVR reﬂection magnitude and the change in
various components of the KCCQ with AVR. AVR indicates aortic valve replacement; KCCQ, Kansas City Cardiomyopathy Questionnaire.
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magnitude does not signiﬁcantly change after AVR, and it
predicts less improvement in quality of life after AVR,
particularly related to heart failure–associated clinical scores,
symptom burden, and physical limitation. Third, we demon-
strated a marked increase in aortic PWV, shown consistently
by independent methods (phase-contrast MRI and arterial
tonometry), accompanied by an important reduction in total
arterial compliance. Fourth, we demonstrated that a shorter
reﬂected wave transit time (a known consequence of
increased aortic PWV) correlates with submaximal exercise
capacity in this population 6 months after AVR. Our
ﬁndings have important implications for our understanding
of the hemodynamic determinants of LV remodeling, extra-
cellular matrix expansion, quality of life, and submaximal
exercise capacity in this patient population.
In patients with severe AS, AVR reduces LV pressure
overload and induces a regression of LV hypertrophy (ie, a
reduction in LV mass). However, few data are available
Figure 5. Thoracic aortic PWV (measured with phase-contrast MRI), CF PWV (measured with tonometry),
and total arterial compliance (measured with pressure–ﬂow relations) before and after AVR. P values were
obtained with the paired t test. AVR indicates aortic valve replacement; CF, carotid–femoral; MRI, magnetic
resonance imaging; PWV, pulse wave velocity; TAC, total arterial compliance.
Figure 6. A, Correlation between reﬂected wave transit time and the 6MWD at 6 months after AVR. B,
Mean 6MWD among subjects with reﬂected wave transit time less than vs greater than or equal to the
median value (40 ms). The P value was obtained with the unpaired t test. 6MWD indicates 6-minute walk
distance; AVR, aortic valve replacement.
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regarding the changes in cellular versus extracellular mass
(which reﬂects interstitial expansion) after AVR. However,
consistent with ﬁndings from the present study, 2 previous
studies demonstrated that LV mass reduction after AVR is
exclusively due to regression of cellular rather than extracel-
lular mass.2,3 Importantly, the amount of extracellular volume
expansion (which correlates with histologic ﬁbrosis in AS)16 is
an independent predictor of adverse outcomes in this patient
population.1,16 Given that extracellular mass does not
substantially regress after correction of LV pressure overload
with valve replacement, a better understanding of additional
factors that inﬂuence the extent of extracellular volume
expansion in severe AS is highly relevant.
The lack of regression of extracellular mass after AVR
suggests that factors other than the pressure overload
imposed by the stenotic valve are involved. Of note, despite
the signiﬁcant pressure overload that the aortic valve imposes
on the left ventricle, it is important to recognize that the left
ventricle experiences the composite load of the valve and the
time-varying load imposed by the arterial tree. Arterial load
also largely determines the “residual” LV afterload after
correction of AS. Whereas severe AS represents a relatively
ﬁxed load, arterial load represents a complex frequency-
dependent load determined by properties of the aortic root,
reﬂected waves from the periphery, and the micro-
vasculature.4,5 Arterial properties determine the relationship
between early and late systolic arterial load to the left
ventricle. In particular, in the presence of aortic stiffening (eg,
that which occurs in older adults), arterial wave reﬂections
(which originate distal to the aortic root) return to the heart
during ejection, increasing pulsatile load in mid- to late systole
and affecting the LV loading sequence. We hypothesized that
wave reﬂections correlate with LV extracellular volume
expansion and an adverse clinical course in severe AS, based
on (1) previous animal data demonstrating that late systolic
load from wave reﬂections (induced by abdominal aortic
banding) in the setting of LV pressure overload causes greater
LV ﬁbrosis compared with an intervention that achieves the
same degree of LV pressure overload without prominent late
systolic load (aortic arch banding) and (2) a series of human
studies demonstrating that late systolic load from wave
reﬂections is associated with LV hypertrophy, diastolic
dysfunction, atrial dysfunction, and an increased risk of heart
failure in various human studies in non-AS populations.4,8–13
In a population of older adults with severe AS, we found
that reﬂection magnitude is associated with myocardial
interstitial expansion, whereas aortic Zc (a key determinant
of early systolic pulsatile arterial load and the only determi-
nant of pulsatile arterial load in the absence of wave
reﬂections) is associated with a lower degree of extracellular
volume expansion. These novel ﬁndings add to accumulating
data demonstrating the deleterious effects of wave reﬂections
on LV structure and function, extending their importance to
severe AS, in which there is severe LV pressure overload from
the stenotic valve. Our studies in this human model of
pressure overload strongly support the notion, suggested by
experimental animal studies, that the loading sequence
adversely inﬂuences LV remodeling independent of pressure
overload per se.
Importantly, we demonstrated that the reﬂection magni-
tude predicts clinical improvement (as measured by the
KCCQ) after correction of severe AS with surgical AVR. In
patients with severe AS, surgical replacement of the severely
stenotic valve improves the pressure overload, but the LV
remains exposed to the underlying arterial loading sequence
determined by wave reﬂections. As expected, there was no
signiﬁcant change in reﬂection magnitude between our pre-
and post-AVR measurements. Reﬂection magnitude measured
at baseline, however, predicted the improvement (or lack
thereof) in overall quality of life and various clinical, symptom,
and physical limitation subscores of the KCCQ. The difference
in KCCQ score improvement between participants with lower
versus higher reﬂection magnitude was large (29 versus 9.37
points) and clinically signiﬁcant. These ﬁndings suggest that
wave reﬂection measurements can predict symptomatic
improvement after AVR but also, more importantly, that wave
reﬂections could be targeted with therapy, which may result in
enhanced symptomatic improvement in this population. Orally
administered inorganic nitrate has been shown to reduce
wave reﬂections arriving at the proximal aorta without
inducing signiﬁcant hypotension or side effects in other
populations.17,18 Future properly designed prospective ran-
domized clinical trials should test whether reducing wave
reﬂections leads to clinical beneﬁts in this population after
successful AVR.
Our study also demonstrates an unexpected pronounced
increase in aortic PWV after AVR. Interestingly, a previous
study demonstrated that surgical AVR was associated with a
signiﬁcant decrease in ascending and descending thoracic
aortic distensibility and a signiﬁcant increase in aortic PWV
measured with in-plane aortic MRI phase-contrast imaging.19
We reproduced this increase in aortic PWV using a similar
MRI method and conﬁrmed this increase using an indepen-
dent method (tonometry-based carotid–femoral PWV mea-
surements), currently considered the noninvasive gold
standard index of large-artery stiffness. Furthermore, we
demonstrate a parallel reduction in total arterial compliance,
a known consequence of large-artery stiffening. Our ﬁndings
are consistent with those reported immediately after
transcatheter AVR by Yotti et al, which included a reduction
in total arterial compliance and increased wave speed
velocity (the analogous of local pulse wave velocity derived
by wave intensity analysis).7 These changes were attributed
to improved transmission of blood momentum to the
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arterial system after transcatheter AVR. It was proposed
that, because of the nonlinear viscoelastic strain of large
arteries, changes in the pressure-mediated deformation of
the aorta after valve replacement may induce stiffer
behavior of the aortic wall. Interestingly, we did not observe
an increase in aortic Zc after transcatheter AVR, which is
not necessarily in disagreement with an increased stiffness
of the aorta, given than Zc is predominantly determined by
aortic geometry rather than stiffness.4,20 In addition to the
aforementioned mechanical processes, it is possible that
additional chronic processes in the arterial wall favor
continued progression or arterial stiffening. At present, the
reasons for increased large-artery stiffness after AVR are
incompletely understood; this represents a key area for
future research.
Interestingly, carotid–femoral PWV, measured by arterial
tonometry, and thoracic aortic PWV, measured by phase-
contrast MRI, demonstrated similar temporal trends but
different absolute values. This is due to the fact that one
method (phase-contrast MRI) interrogates a segment of the
thoracic aorta, whereas the other (tonometry) interrogates a
long segment that includes the descending thoracic aorta, the
abdominal aorta, and muscular arterial segments (which tend
to be stiffer than elastic segments). Furthermore, the
determinants of ascending aortic stiffening may be very
different compared with the descending aortic segment.
In the present study, we demonstrated an inverse
relationship between reﬂected wave transit time (a known
consequence of a high aortic PWV) and submaximal exercise
capacity 6 months after AVR. Reﬂection magnitude and timing
interact to determine the impact of wave reﬂections on
systolic load. After AVR, there was a marked increase in aortic
PWV, demonstrated consistently by independent methods.
With this change, as would be expected, reﬂected wave transit
time became important and was shown to correlate with
submaximal exercise capacity. Interestingly, we also found a
relationship between the 6MWD and both systolic and
diastolic blood pressure. Although the relationship between
reﬂected wave transit time and 6MWD was independent of
systolic blood pressure, it was not independent of diastolic
blood pressure. The latter is consistent with physiologic
principles because a fast return of the reﬂected wave results
in less diastolic pressure augmentation from the reﬂected
wave (and thus lower diastolic blood pressure). Diastolic
augmentation of aortic pressure (as opposed to systolic
augmentation of afterload) is a key hemodynamic determinant
of the myocardial oxygen supply and demand. It remains to be
determined whether delaying reﬂected wave transit time
could restore a more favorable diastolic pressure proﬁle and/
or improve the 6MWD.
Our study should be interpreted in the context of its
strengths and limitations. Strengths of our study include the
use of comprehensive assessments of arterial load, the
dedicated assessment of cellular and interstitial expansion,
the careful selection of study participants, measurement of
PWV by 2 independent methods, and the application of state-
of-the-art methods for analyses of pressure–ﬂow relations.
Our study is the ﬁrst to evaluate the impact of arterial load
quantiﬁed by input impedance (the gold standard method to
quantify arterial load) on LV remodeling, clinical parameters,
and the post-AVR clinical course in this patient population.
Our study also has limitations. We did not assess histologic
ﬁbrosis, although MRI extracellular volume measurements
have been validated against tissue biopsies obtained surgi-
cally during AVR in patients with severe AS.3,16 We did not
perform invasive measurements of pressure and ﬂow, which
would have been unfeasible in many patients, particularly
after AVR. Given the presence of aliasing with signiﬁcant
artifact in the ﬂow waveform in some recordings, we utilized
the LV outﬂow systolic ﬂow proﬁle. We note, however, that
the ﬂow proﬁle in systole is conserved between the LV
outﬂow tract and the proximal aorta; therefore, this is unlikely
to have introduced major error or any systematic bias.
Nevertheless, information in the diastolic ﬂow proﬁle may
have been neglected. We did not directly assess aortic or
carotid pressure but relied on a generalized transfer function,
which may be less accurate in AS. Our sample size was small,
although relatively large effect sizes allowed us to detect
various signiﬁcant relations. However, we were unable to
assess the degree to which arterial properties are indepen-
dent of standard risk factors or whether they mediate or
moderate the effect of such risk factors on LV remodeling
and outcomes after AVR. There were multiple statistical tests,
which could have inﬂated our a error. Our ﬁndings will require
replication in future studies with larger samples. Although our
study occurred across multiple centers, the ﬁndings may not
be generalizable to other populations with severe AS,
particularly younger patients. Our observational study cannot
prove causality, which should be assessed in future exper-
imental studies. Finally, we did not speciﬁcally assess indexes
of wave reﬂection and ventriculoarterial coupling in partici-
pants with low-gradient AS.
In conclusion, our study demonstrates that arterial wave
reﬂections are key correlates of LV interstitial expansion in
patients with severe AS and predict the clinical course
(changes in symptomatic status and quality of life) after AVR.
We also demonstrate the role of arterial load (particularly the
timing of wave reﬂections) on submaximal exercise capacity
6 months after AVR. Our ﬁndings support the importance of
arterial load (in particular, mid- to late systolic load from wave
reﬂections) as a contributor to LV maladaptive remodeling and
poor clinical course in this population. As such, it identiﬁes a
potential therapeutic target that is amenable to currently
available pharmacologic interventions.
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Data S1. 
Supplemental Methods  
 
Arterial Tonometry 
Arterial tonometry was performed immediately before or after CMR using a 
SphygmoCor Px device (AtCor Medical, Inc., Lisle, IL), equipped with a high-fidelity 
Millar applanation tonometer (Millar Instruments, Houston, Tx). Brachial blood pressure 
was obtained using a validated oscillometric device (Omron 705CP-II; HEM-759P-E2). 
Radial waveforms were recorded and calibrated with brachial systolic and diastolic 
pressure. An aortic pressure waveform was obtained via the generalized transfer function 
of the Sphygmocor device. Carotid-femoral pulse wave velocity (CF-PWV) was obtained 
via sequential carotid and femoral tonometry using the QRS complex as a fiducial point 
to assess the pulse transit time between these 2 locations; CF-PWV was computed as 
distance/time (m/s).  
 
Measurements of LV mass 
CMR scans were performed using a 1.5 Tesla (T) whole body MRI scanner (Avanto or 
Espree, Siemens, Malvern, Pennsylvania) equipped with a phase-array cardiac coil. LV 
volumes and ejection fraction (EF) were determined using balanced steady-state free-
precession (SSFP) cine imaging. Typical parameters were as follows: TR=30.6 ms; 
TE=1.3 ms; Phases=30; Slice thickness=8 mm; Matrix size=192x192; Parallel image 
(IPAT) factor=2 to 3. LV short-axis stack cine images were manually traced at end-
diastole and end-systole using CMR42 software (Circle CVI, Calgary, AB, Canada). LV 
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mass (LVM) was computed as the difference between epicardial and endocardial 
volumes, multiplied by myocardial density.  
 
Flow measurements 
To compute the input impedance of the systemic arterial tree (aortic input impedance) 
and assess wave reflection magnitude, knowledge of the time-resolved proximal aortic 
inflow (which equals LV outflow) is required. Proximal aortic flow was measured using 
through plane velocity-encoded phase-contrast imaging with a plane prescribed 
perpendicular to the long axis of the aorta at the level of the right pulmonary artery; 
(typical parameters were as follows: TR~10 msec; TE=3.2 ms; Flip angle=30; 
FOV=340x340; matrix size=256-256; Slice thickness=8 mm; gating=retrospective; 
VENC=at least, 130 cm/sec, prescribed ad hoc to avoid aliasing). Aortic through-plane 
phase-contrast images were processed with Segment software (Segment v1.8R0936; 
Medviso, Lund, Sweden). (1) When significant aliasing impeded a reliable assessment of 
the proximal aortic systolic flow profile, we used the systolic LV outflow profile obtained 
from a 2-D encoded, in-plane phase contrast acquisition in the 3-chamber LV long axis 
plane. In all cases, diastolic outflow was set to zero and the time-integral of the systolic 
flow curve was calibrated to the stroke volume measured via LV cine imaging.  
 
Arterial Load 
Arterial load was quantified using custom-designed software programmed in MATLAB 
(MathWorks, Natick, MA). Briefly, after alignment of central pressure and flow 
waveforms proximal aortic characteristic impedance (ZC), which describes the 
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relationship between pulsatile pressure and flow in the absence of wave reflections, was 
computed in the frequency domain, as the mean value of input impedance moduli at 
higher harmonics (Figure 1). Linear wave separation analysis was performed to 
decompose the pressure waveform into its forward (Pf) and backward (Pb) components. 
This wave separation is based purely on the pulsatile components of pressure and flow, 
and thus does not incorporate mean load (total peripheral resistance). Pf and Pb thus 
fluctuate around zero. The reflected wave transit time was computed as the difference in 
the time at which the forward and backward wave start adding to pressure, as previously 
described (Figure 1).  
 
Quantification of Aortic PWV  
For sensitivity analyses, we performed an additional measurement of aortic PWV using 
phase-contrast MRI, using in-plane velocity encoding from head to foot in the aortic 
“candy cane” view. We defined regions of interest along the aortic lumen, from which 
velocity curves were extracted. A velocity-time curve was obtained from each of several 
ROIs along the aortic centerline. Centerline distance was measured from the magnitude 
images. A spatiotemporal flow profile was generated, and PWV was computed as the slope 
of distance over time, obtained from linear regression. This method effectively computes 
PWV as distance / Δ time using multiple flow curves (rather than just two) along the aortic 
lumen.  
 
Extracellular volume measurements 
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We used a modified Look-Locker inversion recovery (MOLLI) (12) sequence to assess 
T1 times prior to and following the intravenous administration of gadolinium contrast 
(MultiHance, 0.15 mmol/kg of body weight or equivalent) in a mid-ventricular short-axis 
slice. MOLLI sequences were not available in one of the recruiting centers. ECV was 
measured in 31 subjects enrolled across the other sites. Scan parameters for MOLLI 
protocol included: field of view (FOV)~340 mm; matrix size=144x192; slice thickness=6 
mm; repetition time=24.9 ms; echo time=1.18 ms; flip angle=30. Myocardial T1 
measurements were performed before and at several time points at least 10 minutes after-
gadolinium administration.  All available blood and myocardial T1 measurements at >10 
minutes after injection (~10, 15 and 20-30 min) were used to compute the myocardium-
blood partition coefficient (lambda) (5, 14, 18) as the slope of the blood 1/T1 over the 
myocardial 1/T1 change, via linear regression. Lambda was used to compute the LV 
ECV fraction (ECVF) as follows: ECVF=lambda*(1-hematocrit). LV extracellular mass 
was computed as LV mass multiplied by ECVF. LV cellular mass was computed as LV 
mass multiplied by (1-ECVF).  
 
Supplemental Results 
Table S2 shows a comparison of subject who underwent a follow-up MRI (n=30) vs. those 
who did not (n=8). Subjects who could not undergo a follow-up MRI tended to be older 
and demonstrated a lower prevalence of thiazide use at baseline.  
Table S3 shows comparisons of parameters of arterial load between subjects 
stratified according to the median value of extracellular mass at baseline (pre-AVR).  
Some of these comparisons are shown in Figure 3.  
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Figure S2 shows the mean change in various domains of the KCCQ scores 
between the pre-AVR and post-AVR assessments. A positive change (i.e., higher scores 
post-AVR) indicate an improvement. Table S4 shows the correlation coefficients (and 
95%Cis) between reflection magnitude at baseline (pre-AVR) and the improvement in 
various domains in the KCCQ scores after AVR (post-AVR minus pre-AVR value); these 
data are demonstrated in the right panel of Figure 4. 
 
Sensitivity analyses 
There were 3 eligibility waivers during the study. Two subjects were felt to have a mildly 
reduced LV ejection fraction (40-50%) based on clinical imaging (one prior to enrollment 
and one after enrollment). However, in both cases, the LVEF obtained from core lab MRI 
quantification was >50%. A third case underwent a non-gadolinium enhanced cardiac MRI 
with similar LV and flow acquisitions within 1 week prior to enrollment in the study. To 
avoid excessive burden on the participant, a repeat MRI with gadolinium administration 
was waived. Following a recommendation from our data safety monitoring board, we 
conducted an analysis excluding these subjects. In these sensitivity analyses, observed 
trends and estimates were very similar to the overall results (not shown).  
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Table S1. Glossary of key indices of arterial load and ventricular arterial interaction.  
 
Parameter Definition and interpretation 
Aortic input impedance 
(Zin) 
Spectrum of frequencies obtained when aortic pressure and flow waveforms are decomposed into their 
harmonics and pressure harmonics are divided by corresponding flow harmonics. Impedance modulus is 
calculated as pressure modulus/flow modulus and impedance phase is computed as pressure phase minus flow 
phase.  Input impedance is therefore not a single number. Various arterial parameters can be obtained from the 
impedance spectrum. An example of an input impedance spectrum (modulus and phase) is shown in Figure 1 of 
the main manuscript. 
Total peripheral 
resistance 
Ratio of mean pressure to mean flow. Represents the steady (non-pulsatile) vascular load. Determined 
by arteriolar diameter and tone and rarefaction.  
Aortic root 
characteristic 
impedance (Zc) 
Ratio of pulsatile pressure to pulsatile flow in the absence of wave reflection.  It is the pulsatile 
impedance to LV ejection exerted by the aortic root and physically represents the combined effects of 
the inertia of the blood to systolic acceleration and the ability of the aorta to locally store the blood. It 
governs the early systolic pulsatile pressure-flow relation (before arrival of wave reflections to the LV), 
and thus, is a key determinant of early systolic pulsatile arterial load. It is determined by aortic root 
size (smaller roots provide a greater Zc) and to a lesser degree, aortic root wall stiffness (a stiffer root 
wall provides a greater Zc). 
Forward pressure wave 
(Pf) 
Composite wave, travelling from the heart to the periphery, that includes: (1) The primary wave 
generated by the heart; (2) Peripheral wave reflections that are “rectified” (i.e., re-reflected) at the heart 
or the aortic valve. It is a parameter of cross-talk between the LV, the aortic root and peripheral 
reflection sites.  
Backward pressure 
wave (Pb) 
Composite wave, travelling from the periphery towards the heart, influenced by: (1) The magnitude of 
the forward wave; (2) Reflection coefficients at distributed sites along the arterial tree; (3) Pulse wave 
velocity to and from reflection sites. These factors interact in complex ways to form a discrete net 
reflected wave measured at the aortic root. It is a parameter of ventricular-arterial cross-talk.  
Reflection magnitude Ratio of backward/forward wave amplitude. It does not account for the timing of the backward wave. 
Similarly, it does not characterize the contribution of the reflected wave to systole vs. diastole.  It is 
determined by distributes sites of impedance mismatch along the arterial tree (middle-sized muscular 
arterial segments, aortic tapering, (focal) wall stiffening and/or narrowing in conduit arteries, 
microvasculature). 
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Valvuloarterial 
impedance 
Ratio of (mean transvalvular gradient + systolic blood pressure) to stroke volume index. It represents 
the cost in mmHg for each systemic ml of blood pumped by the LV during systole. It is a useful index 
of LV load, but it does not adequately capture the contribution of pulsatile arterial load and the systolic 
loading sequence. Therefore, time-resolved pressure-flow analyses provide information above and 
beyond the valvuloarterial impedance.  
Total arterial 
compliance 
Theoretical compliance of the entire arterial tree. Derived from Windkessel modeling, which does not 
explicitly account for wave propagation and reflection. In the systemic circulation is it provided mostly 
by the ascending aorta and arch and large proximal arteries and to a lesser extent, muscular arteries and 
smaller vessels.   
Pulse wave velocity 
(PWV) 
Propagation velocity of the pulse wave travelling through the arterial wall. PWV is related to the elastic 
modulus of the wall material and the wall thickness/lumen ratio. Currently considered the “gold 
standard” non-invasive metric of arterial stiffness and usually assessed as the ratio of the estimated 
distance between the carotid and femoral artery, and the measured time delay between a hemodynamic 
signal (such as a pressure or flow waveform) measured at these sites. 
 
For a more detailed explanation of these parameters, we refer the reader to the following review paper: Chirinos JA, Segers P. 
Noninvasive evaluation of left ventricular afterload: Part 2: Arterial pressure-flow and pressure-volume relations in humans. 
Hypertension. 2010;56:563-570. 
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Table S2. Comparison on Subjects who did and did not undergo a CMR study after AVR. 
 
Underwent a  
Follow-up CMR (n=30) 
Did not undergo  
Follow-up CMR (n=8) P value 
Age 70.8±9.3 77.1±8.1 0.09 
Male sex 21 (70.00%) 5 (62.50%) 0.69 
Race/Ethnicity     1.00 
   Caucasian 28 (93.33%) 8 (100.00%)  
   African American 2 (6.67%) 0 (0.00%)   
BMI, kg/m2 30.9±6 28.1±5.7 0.24 
Serum creatinine 0.911±0.21 0.876±0.209 0.68 
Aortic valve area (cm2) 0.751±0.139 0.675±0.157 0.19 
Aortic valve area index (cm2/m2) 0.372±0.082 0.34±0.072 0.32 
Mean transvalvular gradient (mmHg) 47.1±13.1 52.9±18.7 0.32 
Peak transvalvular gradient (mmHg) 88.3±31.5 74.1±21.7 0.15 
Valvulo-arterial impedance, 
mmHg•ml−1•m2 4.17±1.1 4.48±1.05 0.48 
Systolic Blood Pressure mmHg 129 (126,153) 139 (128,160) 0.51 
Diastolic Blood Pressure, mmHg 72.9±9.6 73.8±11.2 0.83 
Mean arterial Pressure, mmHg 99.7±13.4 94.9±12.6 0.37 
Pulse pressure, mmHg 70.6±26.4 63±6.8 0.43 
Heart rate, bpm 62.5 (57,73) 65 (54.5,73.5) 0.97 
Angina 1 (3.33%) 0 (0.00%) 1.00 
Dyspnea 22 (73.33%) 4 (50.00%) 0.23 
Diabetes Mellitus 9 (30.00%) 3 (37.50%) 0.69 
Hypertension 27 (90.00%) 6 (75.00%) 0.28 
NYHA Class   0.36 
    I  7 (23.33%) 3 (37.50%)  
    II 14 (46.67%) 5 (62.50%)  
    III/IV 7 (23.33%) 0 (0.00%)  
Medication Use    
   Aspirin 23 (76.67%) 8 (100.00%) 0.31 
   ACE Inhibitors or ARBs 17 (56.67%) 7 (87.50%) 0.22 
   Beta Blockers 18 (60.00%) 4 (50.00%) 0.70 
   Calcium Channel Blockers 7 (23.33%) 1 (12.50%) 0.66 
   Thiazide diuretics 12 (40.00%) 0 (0.00%) 0.04 
   Loop diuretics 6 (20.00%) 0 (0.00%) 0.31 
   Hydralazine use 0 (0.00%) 1 (12.50%) 0.21 
   Long Acting Nitrate use 0 (0.00%) 1 (12.50%) 0.21 
   Insulin Use 3 (10.00%) 1 (12.50%) 1.00 
Numbers represent mean±SD for normally-distributed variables, median (IQR) for non-normally 
distributed variables, or counts (%). P values were obtained using the unpaired t test for normally 
distributed variables, the Kruskall-Wallis test for non-normally distributed variables, and the chi-
square or Fisher exact test for proportions, as appropriate. 
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Table S3. Comparisons of Parameters of Arterial Load between subjects with Higher vs Lower Extracellular Mass at baseline 
(pre-AVR), stratified according to the median value. 
 
 
Extracellular Mass<35.6 g 
Mean (95%CI) 
Extracellular Mass (g) ≥35.6 g 
Mean (95%CI) P value 
Reflection Magnitude 0.54 (0.47 to 0.60) 0.68 (0.61 to 0.74) 0.006 
Aortic Zc, dynes·s/cm5 96.9 (73.3 to 120.5) 56.3 (33.5 to 79.2) 0.025 
Reflected Wave Transit time, s 0.045 (0.035 to 0.054) 0.039 (0.03 to 0.048) 0.42 
Carotid-femoral PWV, m/s 8.8 (6.6 to 10.9) 9.9 (7.9 to 12) 0.437 
Total peripheral resistance, dynes·s/cm5 1387 (1221 to 1553) 1175 (1014 to 1335) 0.083 
Valvuloarterial impedance, mmHg·ml−1·m2 4.21 (3.73 to 4.68) 3.55 (3.08 to 4.03) 0.066 
Systolic blood pressure (mmHg) 142 (135 to 150) 134 (126 to 142) 0.1358 
Diastolic blood pressure (mmHg) 74.8 (70.6 to 79) 72.7 (68.5 to 76.9) 0.5001 
Pulse pressure (mmHg) 67.5 (60.8 to 74.3) 61.1 (54.4 to 67.9) 0.1974 
  D
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Table S4. Correlation Between Reflection Magnitude at Baseline (pre-AVR) and the improvement in KCCQ after AVR 
(change compared to pre-AVR value). 
 
Correlation 
Coefficient  95% CI 
P 
value 
Physical Limitation Score change -0.52 -0.85 to -0.19 0.003 
Symptom Stability Score change 0.12 -0.25 to 0.49 0.52 
Symptom Frequency Score change -0.32 -0.67 to 0.04 0.076 
Symptom burden Score change -0.53 -0.85 to -0.21 0.002 
Total Symptom Score change -0.46 -0.79 to -0.12 0.009 
Self-Efficacy Score change 0.17 -0.2 to 0.54 0.356 
Quality of Life Score change  -0.38 -0.72 to -0.03 0.034 
Social Limitation Score change -0.43 -0.78 to -0.08 0.018 
Overall Summary Score change -0.51 -0.83 to -0.19 0.003 
Clinical summary Score change -0.50 -0.82 to -0.17 0.004 
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Figure S1. Study subject flow and procedures. 
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Figure S2. Mean change in KCCQ scores between the pre-AVR and post-AVR assessments. A positive change (i.e., higher 
scores post-AVR) indicate an improvement.  
  
KCCQ=Kansas City Cardiomyopathy Questionnaire. AVR=aortic valve replacement. 
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